Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

GARDASIL Vaccine Impact in Population Study.

Next Previous
Search
Trial Profile

GARDASIL Vaccine Impact in Population Study.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 11 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 16 May 2018 Results assessing the prevalence of human papillomavirus infections before and after introduction of quadrivalent HPV vaccination, published in the Vaccine
  • 12 Dec 2015 Change in Time Frame after Gardasil licensure:- changed from 2011-2012 to 2007-2011. Patient ages also specifically mentioned in the timepoints as per ClinicalTrials.gov record.
  • 01 Jan 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top